Cargando…
PD-1抑制剂Nivolumab对CD19嵌合抗原受体T细胞体外增殖和杀伤活性的影响
OBJECTIVE: To Evaluation the effect of PD-1 inhibitor Nivolumab on the proliferation and cytotoxicity of anti-CD19 chimeric antigen receptor T cells (CD19-CAR-T) in vitro. METHODS: Five patients with high PD-1 expression in peripheral blood and five healthy volunteers were selected. These peripheral...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342209/ https://www.ncbi.nlm.nih.gov/pubmed/30122019 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.07.011 |
Ejemplares similares
-
CD19嵌合抗原受体T细胞对不同淋巴瘤细胞杀伤活性的研究
Publicado: (2017) -
血液肿瘤嵌合抗原受体自然杀伤细胞治疗研究进展
Publicado: (2022) -
CD19嵌合抗原受体T细胞制备条件优化及其体内外杀伤作用研究
Publicado: (2022) -
嵌合抗原受体T细胞的结构演变及展望
Publicado: (2020) -
嵌合抗原受体T细胞相关脑病综合征一例
Publicado: (2020)